Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Ingrid J. Hall"'
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Multimorbidity is increasing among adults in the United States. Yet limited research has examined multimorbidity clusters in persons aged 50 years and older with and without a history of cancer. An increased understanding of multi
Externí odkaz:
https://doaj.org/article/e959a719859b4e6db4596133452834db
Autor:
Stephanie B. Wheeler, Tzy-Mey Kuo, Anne Marie Meyer, Christa E. Martens, Kristen M. Hassmiller Lich, Florence K.L. Tangka, Lisa C. Richardson, Ingrid J. Hall, Judith Lee Smith, Maria E. Mayorga, Paul Brown, Trisha M. Crutchfield, Michael P. Pignone
Publikováno v:
Preventive Medicine Reports, Vol 6, Iss C, Pp 9-16 (2017)
Understanding multilevel predictors of colorectal cancer (CRC) screening test modality can help inform screening program design and implementation. We used North Carolina Medicare, Medicaid, and private, commercially available, health plan insurance
Externí odkaz:
https://doaj.org/article/3e0b8fe7f03745aba8cae6a13fa98a6f
Publikováno v:
Preventive Medicine Reports, Vol 14, Iss , Pp - (2019)
Many overweight women or women with obesity do not acknowledge their high weight status and may be unaware of their elevated cancer risk. We explored the relationship between weight status and women's perceived risk of colorectal (CRC) and breast can
Externí odkaz:
https://doaj.org/article/783fb5a99e034aaabfc2decb3c9c09d1
Autor:
Sun Hee Rim, Ingrid J. Hall, Thomas B. Richards, Trevor D. Thompson, Lisa C. Richardson, Louie E. Ross, Marcus Plescia
Publikováno v:
Health Services Research & Managerial Epidemiology, Vol 1 (2014)
Background: Limited information exists on primary care physicians’ (PCPs) use of the prostate-specific antigen (PSA) test by patient risk category. We describe PCP responses to hypothetical patient scenario (PS) involving PSA testing among high-ris
Externí odkaz:
https://doaj.org/article/96385315ee0c4dbb88ba5f233ed91ad3
Autor:
Louie E. Ross, Ingrid J. Hall
Publikováno v:
Journal of Primary Care & Community Health, Vol 5 (2014)
Introduction: Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. African American (AA) men have greater prostate cancer burden than other men. Little is known about AA primary care p
Externí odkaz:
https://doaj.org/article/a8782ac042c14c16b9a8f11e5bf9edc0
Autor:
Ingrid J. Hall PhD, MPH, Louie E. Ross PhD, Yhenneko J. Taylor MS, Lisa C. Richardson MD, MPH
Publikováno v:
Journal of Primary Care & Community Health, Vol 2 (2011)
Background: Major health organizations recommend that physicians discuss the risks and benefits of prostate cancer screening with men before ordering tests. The length of time that health care providers spend discussing prostate cancer screening-rela
Externí odkaz:
https://doaj.org/article/546090b7f06445f692e7e58834f0cc2a
Autor:
David H. Howard, Ingrid J. Hall
Publikováno v:
Urology Practice. 10:179-185
Why men with a low-risk prostate cancer select and stay on active surveillance: A qualitative study.
Autor:
Aaron T Seaman, Kathryn L Taylor, Kimberly Davis, Kenneth G Nepple, John H Lynch, Anthony D Oberle, Ingrid J Hall, Robert J Volk, Heather Schacht Reisinger, Richard M Hoffman
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225134 (2019)
ObjectiveActive surveillance (AS) is an increasingly utilized strategy for monitoring men with low-risk prostate cancer (PCa) that allows them to defer active treatment (AT) in the absence of cancer progression. Studies have explored reasons for sele
Externí odkaz:
https://doaj.org/article/09afd402e2064e7ba1c9ef31e36480b5
Publikováno v:
Cancer Causes Control
PURPOSE: Despite widespread promotion of breast and cervical cancer (BCC) screening, uptake remains low in rural communities. Barriers to healthcare, which often result in poorer health outcomes, differentially impact residents of rural communities.
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: We sought to characterize recent prostate cancer incidence, distant stage diagnosis, and mortality rates by region, race/ethnicity, and age group. Methods: In SEER*Stat, we examined age-specific and age-adjusted prostate cancer incidence,